Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Telesis Bio Inc. - 15-12G, Securities registration termination | - | SEC Filings | ||
08.11.24 | Telesis Bio secures $3 million in promissory notes | 2 | Investing.com | ||
08.11.24 | Telesis Bio sichert sich 3 Millionen US-Dollar durch Schuldscheine | 2 | Investing.com Deutsch | ||
TELESIS BIO Aktie jetzt für 0€ handeln | |||||
08.11.24 | Telesis Bio Inc. - 8-K, Current Report | - | SEC Filings | ||
07.11.24 | Telesis Bio Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
25.10.24 | Telesis Bio announces departure of Chief Legal Officer | 1 | Investing.com | ||
25.10.24 | Telesis Bio Inc. - 8-K, Current Report | 3 | SEC Filings | ||
26.09.24 | What's Going On With Telesis Bio Shares Thursday? | 3 | Benzinga.com | ||
26.09.24 | HotStocks USA: +105 % bei Telesis Bio | 3 | stock3.com | ||
26.09.24 | Pre-market Movers: Telesis Bio, VS MEDIA, MDxHealth, Micron Technology, Pagaya Technologies | 577 | AFX News | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.45 A.M. ET).In the Green Telesis Bio, Inc. (TBIO) is up... ► Artikel lesen | |
26.09.24 | Telesis Bio partners with Danaher company Beckman Coulter | 13 | Seeking Alpha | ||
26.09.24 | Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket | 7 | Benzinga.com | ||
25.09.24 | Telesis Bio Stock Is Soaring Wednesday: What's Going On? | 2 | Benzinga.com | ||
25.09.24 | Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis | 2 | GlobeNewswire (USA) | ||
20.09.24 | Telesis Bio Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
19.09.24 | HotStocks USA: Rezolve AI + 207%, Telesis Bio + 167 % | 20 | stock3.com | ||
11.09.24 | Pre-market Movers: Quhuo, Telesis Bio, Designer Brands, BIO-key International, Syra Health | 596 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.45 A.M. ET).In the Green Quhuo Limited (QH) is up over 92% at $2.56.
BIO-key... ► Artikel lesen | |
11.09.24 | Telesis Bio Seeks Delisting From Nasdaq; Stock Down 57% In Pre-market | 2 | RTTNews | ||
10.09.24 | Telesis Bio to delist its securities from Nasdaq | 1 | Seeking Alpha | ||
10.09.24 | Telesis Bio to delist from Nasdaq by end of September | 3 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 109,20 | +0,18 % | BioNTech Aktie testet Widerstände: Kommt der nächste Ausbruch? | Die BioNTech Aktie befindet sich in einer spannenden charttechnischen Phase mit einem NASDAQ-Schlusskurs vom Freitag bei 122,85 US-Dollar und einer insgesamt positiven Entwicklung seit Mitte des Jahres.... ► Artikel lesen | |
EVOTEC | 7,990 | +3,30 % | Evotec, flatexDEGIRO, Hypoport, K+S, Puma, United Internet u.a. - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
BB BIOTECH | 40,550 | -0,12 % | BB Biotech Aktie: Positiver Blick auf die Zukunft! | Die BB Biotech AG verzeichnet einen positiven Start ins neue Jahr. Der führende Biotechnologie-Investor konnte im ersten Monat 2025 einen Kursanstieg von 1,40 Prozent verbuchen. Mit einem aktuellen... ► Artikel lesen | |
AMGEN | 264,70 | -0,08 % | Amgen Aktie: Starkes Wachstum sichert Zukunft | Die Amgen Aktie zeigt sich zum Jahresstart 2025 in robuster Verfassung. Der Biotechnologie-Konzern verzeichnete am 18. Januar einen Kursanstieg von 0,99% auf 272,11 USD. Besonders bemerkenswert ist... ► Artikel lesen | |
EPIGENOMICS | 1,250 | -3,85 % | EQS-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Epigenomics AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Epigenomics AG: Vorabbekanntmachung über die... ► Artikel lesen | |
ILLUMINA | 134,90 | +1,44 % | Illumina: If There Is a Monster in Loch Ness, This Geneticist Will Find It | NORTHAMPTON, MA / ACCESSWIRE / January 16, 2025 / IlluminaProfessor Neil Gemmell has a new plan to expand environmental DNA collection from the legendary lakeOriginally published on Illumina News CenterThe... ► Artikel lesen | |
CRISPR THERAPEUTICS | 39,500 | +0,51 % | CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell? | ||
REGENERON PHARMACEUTICALS | 668,80 | +0,81 % | Regeneron To Invest $119.5 Mln In Truveta's Financing Round, Launch Truveta Genome Project | SAN DIEGO (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN), Monday announced a collaboration with software company Truveta, Inc. and its collective of U.S. healthy systems, offering a strategic... ► Artikel lesen | |
ORGANOVO | 0,337 | -8,81 % | ORGANOVO HOLDINGS, INC. - 8-K, Current Report | ||
SANGAMO THERAPEUTICS | 1,046 | -1,90 % | Sangamo To Regain Rights To Hemophilia Therapy After Pfizer's Decides To Terminate Collaboration | NEW YORK CITY (dpa-AFX) - Genomic medicine company Sangamo Therapeutics, Inc. (SGMO) Monday announced that it will regain development and commercialization rights to giroctocogene fitelparvovec... ► Artikel lesen | |
INTELLIA THERAPEUTICS | 9,318 | +0,74 % | Intellia Loses 21.6% in a Week: How Should You Play the Stock? | ||
EDITAS MEDICINE | 1,182 | -0,88 % | Editas Medicine, Inc.: Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities | Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel in vivo treatment for sickle cell disease and beta thalassemia... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,450 | +2,04 % | Defence Therapeutics Inc.: Defence to Connect with Industry Leaders and Potential Partners During the JP Morgan Healthcare Conference in San Francisco. Plans to Expand the Next Generation of Radio-Immuno Conjugates in 2025 | Montreal, Quebec--(Newsfile Corp. - January 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company") a Canadian biopharmaceutical company developing radiopharmaceuticals... ► Artikel lesen | |
PACIFIC BIOSCIENCES OF CALIFORNIA | 1,619 | +1,15 % | PacBio Expects Q4, FY24 Revenues To Decline | WASHINGTON (dpa-AFX) - PacBio (PACB), Tuesday announced preliminary revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154.0 million representing a year-over-year... ► Artikel lesen | |
CARDIOL THERAPEUTICS | 1,176 | +0,17 % | Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research): Buy / Kursziel: USD 8,50 | Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH 22.11.2024 / 11:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.... ► Artikel lesen |